Adult Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
An Open-Label Treatment, Investigator-Initiated Study, on the Duration and Efficacy of Azstarys (Serdexmethylphenidate and Dexmethylphenidate) on Adult ADHD Symptoms and Executive Function in Early Evening
This is a single-site study. One purpose of this trial is to extend the safety and efficacy evidence basis for Azstarys in adults with ADHD. This open-label, treatment study will examine the efficacy of Azstarys on ADHD symptoms using the AISRS 18-item total score on the AISRS-expanded; the Adult ADHD Investigator Symptom Rating Scale. The investigators will also examine Executive Function later in the day (early evening, about 12 hours after first morning dosing).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03721588 -
Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD
|
||
| Completed |
NCT03324581 -
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
|
Phase 2 | |
| Active, not recruiting |
NCT06221930 -
Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder
|
N/A | |
| Completed |
NCT02160262 -
Open-label Safety Study in Adults With ADHD
|
Phase 3 | |
| Completed |
NCT02276209 -
Dasotraline Adult ADHD Study
|
Phase 3 | |
| Completed |
NCT01692782 -
Adult Attention Deficit Hyperactivity Disorder
|
Phase 2 | |
| Completed |
NCT01798381 -
Essential Fatty Acids in Adult ADHD
|
Phase 3 | |
| Completed |
NCT00553319 -
Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence
|
Phase 2/Phase 3 |